Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C. (Q43033106)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Sheng-Shun Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Lin-Shien Fu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Chi-Sen Chang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Hong-Zen Yeh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Gran-Hum Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

1 reference

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology and Hepatology

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1789-1793

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

Course and outcome of hepatitis C

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Interaction between the hepatitis C virus and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Lower th-1/th-2 ratio before interferon therapy may favor long-term virological responses in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

Soluble CD30 serum level in HCV-positive chronic active hepatitis: A surrogate marker of disease activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04677.X

10.1111/J.1440-1746.2006.04677.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17074015%20AND%20SRC:MED&resulttype=core&format=json

release_aj2zk2dotfdzdgeh726gxynflu

21 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aj2zk2dotfdzdgeh726gxynflu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference